Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Annals of Surgical Oncology
|
October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy
N Q Mirza, G Vlastos, F Meric, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2016
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
M J Overman, V Morris, B Kee, et al.
BMC Cancer
|
October 18, 2015
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
X Liu, G C George, A M Tsimberidou, et al.
JCO Precision Oncology
|
September 14, 2019
Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations
E Ileana Dumbrava, L Brusco, M Daniels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2019
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group
D Mandelker, M Donoghue, S Talukdar, et al.
ESMO Open
|
August 6, 2025
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors
M H Derbala, J Hajjar, B Stephen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 2024
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M F Mosele, C B Westphalen, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2017
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients
K Allenson, J Castillo, F A San Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2020
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, et al.
ESMO Open
|
March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
T Cascone, R L Sacks, I M Subbiah, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Annals of Surgical Oncology
|
October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy
N Q Mirza, G Vlastos, F Meric, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2016
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
M J Overman, V Morris, B Kee, et al.
BMC Cancer
|
October 18, 2015
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
X Liu, G C George, A M Tsimberidou, et al.
JCO Precision Oncology
|
September 14, 2019
Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations
E Ileana Dumbrava, L Brusco, M Daniels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2019
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group
D Mandelker, M Donoghue, S Talukdar, et al.
ESMO Open
|
August 6, 2025
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors
M H Derbala, J Hajjar, B Stephen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 2024
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M F Mosele, C B Westphalen, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2017
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients
K Allenson, J Castillo, F A San Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2020
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, et al.
ESMO Open
|
March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
T Cascone, R L Sacks, I M Subbiah, et al.
Page
of 7